Compare Unichem Lab with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB STRIDES PHARMA SCIENCE UNICHEM LAB/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 89.8 168.8 53.2% View Chart
P/BV x 0.7 1.8 40.5% View Chart
Dividend Yield % 1.5 0.4 337.0%  

Financials

 UNICHEM LAB   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    UNICHEM LAB
Mar-21
STRIDES PHARMA SCIENCE
Mar-21
UNICHEM LAB/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs3601,000 36.0%   
Low Rs122304 40.0%   
Sales per share (Unadj.) Rs175.4369.7 47.4%  
Earnings per share (Unadj.) Rs4.939.6 12.4%  
Cash flow per share (Unadj.) Rs16.962.6 27.0%  
Dividends per share (Unadj.) Rs4.002.50 160.0%  
Avg Dividend yield %1.70.4 433.2%  
Book value per share (Unadj.) Rs362.0309.1 117.1%  
Shares outstanding (eoy) m70.4189.68 78.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.41.8 77.8%   
Avg P/E ratio x48.916.4 297.4%  
P/CF ratio (eoy) x14.210.4 136.9%  
Price / Book Value ratio x0.72.1 31.5%  
Dividend payout %81.26.3 1,288.3%   
Avg Mkt Cap Rs m16,95458,465 29.0%   
No. of employees `000NANA-   
Total wages/salary Rs m3,0705,501 55.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,35133,159 37.2%  
Other income Rs m502734 68.4%   
Total revenues Rs m12,85333,893 37.9%   
Gross profit Rs m9116,702 13.6%  
Depreciation Rs m8442,063 40.9%   
Interest Rs m511,501 3.4%   
Profit before tax Rs m5183,872 13.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m172317 54.2%   
Profit after tax Rs m3473,555 9.8%  
Gross profit margin %7.420.2 36.5%  
Effective tax rate %33.18.2 405.0%   
Net profit margin %2.810.7 26.2%  
BALANCE SHEET DATA
Current assets Rs m13,77328,172 48.9%   
Current liabilities Rs m5,05827,383 18.5%   
Net working cap to sales %70.62.4 2,966.0%  
Current ratio x2.71.0 264.7%  
Inventory Days Days155165 93.6%  
Debtors Days Days740122 607.0%  
Net fixed assets Rs m17,34439,996 43.4%   
Share capital Rs m141897 15.7%   
"Free" reserves Rs m25,35026,823 94.5%   
Net worth Rs m25,49127,719 92.0%   
Long term debt Rs m08,826 0.0%   
Total assets Rs m31,11868,168 45.6%  
Interest coverage x11.13.6 310.7%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.40.5 81.6%   
Return on assets %1.37.4 17.2%  
Return on equity %1.412.8 10.6%  
Return on capital %2.214.7 15.2%  
Exports to sales %82.851.1 162.0%   
Imports to sales %14.40-   
Exports (fob) Rs m10,22416,941 60.4%   
Imports (cif) Rs m1,780NA-   
Fx inflow Rs m10,22435,084 29.1%   
Fx outflow Rs m1,780392 454.2%   
Net fx Rs m8,44434,692 24.3%   
CASH FLOW
From Operations Rs m3314,814 6.9%  
From Investments Rs m-736-5,208 14.1%  
From Financial Activity Rs m-1,212-158 767.2%  
Net Cashflow Rs m-1,541-564 273.2%  

Share Holding

Indian Promoters % 50.9 29.4 173.5%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 10.6 40.4 26.3%  
FIIs % 1.5 25.8 5.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.1 70.4 69.7%  
Shareholders   33,892 96,976 34.9%  
Pledged promoter(s) holding % 0.0 26.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   BROOKS LAB  AUROBINDO PHARMA  THEMIS MEDICARE  FERMENTA BIOTECH  ALEMBIC PHARMA  



Today's Market

HUL's Quarterly Performance, Tata Motors on EV Battery Prices, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a flat note yesterday. Dalal street's greatest winning streak in over ten months came to an end when benchmark indices fell for the first time in eight sessions.

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY22); Net Profit Down 253.9% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (down 253.9% YoY). Sales on the other hand came in at Rs 7 bn (down 12.0% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY21); Net Profit Down 46.4% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 621 m (down 46.4% YoY). Sales on the other hand came in at Rs 8 bn (up 13.6% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY21); Net Profit Up 184.5% (Quarterly Result Update)

Aug 20, 2020 | Updated on Aug 20, 2020

For the quarter ended June 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 1 bn (up 184.5% YoY). Sales on the other hand came in at Rs 8 bn (up 14.0% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY21); Net Profit Up 184.5% (Quarterly Result Update)

Aug 20, 2020 | Updated on Aug 20, 2020

For the quarter ended June 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 1 bn (up 184.5% YoY). Sales on the other hand came in at Rs 8 bn (up 14.0% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Oct 19, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS